Skip to main content
. 2020 Nov 23;20:83. doi: 10.1186/s40644-020-00358-3

Table 1.

Clinical characteristics of gastric cancer patients in the training and validation cohorts

Clinical characteristics Training cohort (n = 377) p value Validation cohort (n = 162) p value
Intestinal type (n = 173) Diffuse type (n = 204) Intestinal type (n = 70) Diffuse type (n = 92)
Age, mean ± SD, years 65.2 ± 8.8 62.2 ± 9.6 0.0042* 64.3 ± 8.8 62.6 ± 11.0 0.3045
Sex, No. (%) 0.0702 0.8752
male 130 (75.1) 135 (66.2) 54 (77.1) 70 (76.1)
female 43 (24.9) 69 (33.8) 16 (22.9) 22 (23.9)
CT T stage, No. (%) 0.0247* 0.6810
T1–2 53 (30.6) 38 (18.6) 18 (25.7) 19 (20.7)
T3 75 (43.4) 102 (50.0) 25 (35.7) 38 (41.3)
T4 45 (26.0) 64 (31.4) 27 (38.6) 35 (38.0)
CT N stage, No. (%) 0.0061* 0.0430*
N0 46 (26.6) 45 (22.1) 10 (14.3) 22 (23.9)
N1 80 (46.2) 72 (35.3) 35 (50.0) 26 (28.3)
N2 40 (23.1) 63 (30.9) 20 (28.6) 34 (37.0)
N3 7 (4.0) 24 (11.8) 5 (7.1) 10 (10.9)

NOTE. p values are derived from univariate analysis between each clinical characteristic and the Lauren classification. Abbreviations: SD Standard deviation, CT Computed tomography. *p value < .05